Search research articles
Contact Us
Filters
Showing results (121-130 of 599) with videos related to
Page
of 60
Sort By:
Current Pharmaceutical Design
|
May 18, 2012
Novel insights in molecular mechanisms of CLL
Nicola Zanesi, Veronica Balatti, Arianna Bottoni, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2002
Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines
Luca Roz, Marcella Gramegna, Hideshi Ishii, et al.
RNA Biology
|
January 9, 2013
A new role for microRNAs, as ligands of Toll-like receptors
Muller Fabbri, Alessio Paone, Federica Calore, et al.
The Lancet. Oncology
|
December 11, 2002
FHIT: from gene discovery to cancer treatment and prevention
Yuri Pekarsky, Nicola Zanesi, Alexey Palamarchuk, et al.
Cell
|
May 5, 2009
SnapShot: MicroRNAs in Cancer
Riccardo Spizzo, Milena S Nicoloso, Carlo M Croce, et al.
Journal of Nucleic Acids Investigation
|
June 14, 2011
MicroRNAs in mouse models of lymphoid malignancies
Nicola Zanesi, Yuri Pekarsky, Francesco Trapasso, et al.
Gene Expression
|
February 21, 2015
The long journey of TCL1 transgenic mice: lessons learned in the last 15 years
Yuri Pekarsky, Alessandra Drusco, Prasanthi Kumchala, et al.
Cell Cycle (Georgetown, Tex.)
|
August 23, 2008
Mechanisms of microRNA deregulation in human cancer
Shan Deng, George Adrian Calin, Carlo M Croce, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 8, 2026
<i>MiR-155</i>-driven loss of ICOSL and SOCS1 in EBV+ gastric cancers renders abundant cytotoxic T cells ineffective, enabling immune evasion
Gerard J Nuovo, Koshi Mimori, Hajime Otsu, et al.
Current Opinion in Pharmacology
|
November 21, 2017
MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials
Esmerina Tili, Jean-Jacques Michaille, Victoria Piurowski, et al.
Page
of 60
Search research articles
Search
Showing results (121-130 of 599) with videos related to
Sort By:
Page
of 60
Current Pharmaceutical Design
|
May 18, 2012
Novel insights in molecular mechanisms of CLL
Nicola Zanesi, Veronica Balatti, Arianna Bottoni, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2002
Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines
Luca Roz, Marcella Gramegna, Hideshi Ishii, et al.
RNA Biology
|
January 9, 2013
A new role for microRNAs, as ligands of Toll-like receptors
Muller Fabbri, Alessio Paone, Federica Calore, et al.
The Lancet. Oncology
|
December 11, 2002
FHIT: from gene discovery to cancer treatment and prevention
Yuri Pekarsky, Nicola Zanesi, Alexey Palamarchuk, et al.
Cell
|
May 5, 2009
SnapShot: MicroRNAs in Cancer
Riccardo Spizzo, Milena S Nicoloso, Carlo M Croce, et al.
Journal of Nucleic Acids Investigation
|
June 14, 2011
MicroRNAs in mouse models of lymphoid malignancies
Nicola Zanesi, Yuri Pekarsky, Francesco Trapasso, et al.
Gene Expression
|
February 21, 2015
The long journey of TCL1 transgenic mice: lessons learned in the last 15 years
Yuri Pekarsky, Alessandra Drusco, Prasanthi Kumchala, et al.
Cell Cycle (Georgetown, Tex.)
|
August 23, 2008
Mechanisms of microRNA deregulation in human cancer
Shan Deng, George Adrian Calin, Carlo M Croce, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 8, 2026
<i>MiR-155</i>-driven loss of ICOSL and SOCS1 in EBV+ gastric cancers renders abundant cytotoxic T cells ineffective, enabling immune evasion
Gerard J Nuovo, Koshi Mimori, Hajime Otsu, et al.
Current Opinion in Pharmacology
|
November 21, 2017
MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials
Esmerina Tili, Jean-Jacques Michaille, Victoria Piurowski, et al.
Page
of 60